The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice
Abstract LH-21 is a triazol derivative that has been described as a low-permeant neutral CB1 antagonist, though its pharmacology is still unclear. It has been associated with anti-obesity actions in obese rats. However, its role in preventing type 2 diabetes (T2D) onset have not been studied yet. Gi...
Guardado en:
Autores principales: | Silvana Y. Romero-Zerbo, Inmaculada Ruz-Maldonado, Vanesa Espinosa-Jiménez, Alex Rafacho, Ana I. Gómez-Conde, Lourdes Sánchez-Salido, Nadia Cobo-Vuilleumier, Benoit R. Gauthier, Francisco J. Tinahones, Shanta J. Persaud, Francisco J. Bermúdez-Silva |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/37b7287839a5497faf990573a8d0dd27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human Luteinizing Hormone and Chorionic Gonadotropin Display Biased Agonism at the LH and LH/CG Receptors
por: Laura Riccetti, et al.
Publicado: (2017) -
Síndrome HaNDL / HaNDL Syndrome / Síndrome HaNDL
por: Camilo Ernesto Barros-Gutiérrez, MD., Esp., et al.
Publicado: (2015) -
Medical Cannabis and Cannabinoids
Publicado: (2020) -
Cannabinoids in trigeminal neuralgia
por: Antonino Genovese, et al.
Publicado: (2021) -
Regulation of post-Golgi LH3 trafficking is essential for collagen homeostasis
por: Blerida Banushi, et al.
Publicado: (2016)